Cited by

• Optimization of T-cell Reactivity by Exploiting TCR Chain Centricity for the Purpose of Safe and Effective Antitumor TCR Gene Therapy.

  Ochi T, Nakatsugawa M, Chamoto K, Tanaka S, Yamashita Y, Guo T, Fujiwara H, Yasukawa M, Butler MO, Hirano N. Ochi T, et al. Cancer Immunol Res. 2015 Sep;3(9):1070-81. doi: 10.1158/2326-6066.CIR-14-0222. Epub 2015 May 5. Cancer Immunol Res. 2015. PMID: 25943533 Free PMC article.
• Evidence that the leukocyte-common antigen is required for antigen-induced T lymphocyte proliferation.

  Pingel JT, Thomas ML. Pingel JT, et al. Cell. 1989 Sep 22;58(6):1055-65. doi: 10.1016/0092-8674(89)90504-7. Cell. 1989. PMID: 2550143 Free PMC article.
• Highly conserved T-cell receptor junctional regions. Evidence for selection at the protein and the DNA level.

  Sorger SB, Hedrick SM. Sorger SB, et al. Immunogenetics. 1990;31(2):118-22. doi: 10.1007/BF00661222. Immunogenetics. 1990. PMID: 2303278 No abstract available.
• Predicted complementarity determining regions of the T cell antigen receptor determine antigen specificity.

  Katayama CD, Eidelman FJ, Duncan A, Hooshmand F, Hedrick SM. Katayama CD, et al. EMBO J. 1995 Mar 1;14(5):927-38. doi: 10.1002/j.1460-2075.1995.tb07074.x. EMBO J. 1995. PMID: 7534228 Free PMC article.
• "Exon-shuffling" maps control of antibody- and T-cell-recognition sites to the NH2-terminal domain of the class II major histocompatibility polypeptide A beta.

  Germain RN, Ashwell JD, Lechler RI, Margulies DH, Nickerson KM, Suzuki G, Tou JY. Germain RN, et al. Proc Natl Acad Sci U S A. 1985 May;82(9):2940-4. doi: 10.1073/pnas.82.9.2940. Proc Natl Acad Sci U S A. 1985. PMID: 3921966 Free PMC article.